Annual report pursuant to Section 13 and 15(d)

Common Stock - Additional Information (Detail)

v3.3.1.900
Common Stock - Additional Information (Detail) - USD ($)
3 Months Ended 12 Months Ended
Apr. 30, 2015
Apr. 27, 2015
Jul. 02, 2014
Aug. 13, 2015
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
May. 21, 2015
May. 20, 2015
May. 29, 2014
May. 28, 2014
Jun. 30, 2013
May. 24, 2013
May. 23, 2013
Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Common stock, shares authorized         75,000,000 75,000,000                  
Common stock, par value         $ 0.001 $ 0.001                  
Preferred stock, shares authorized         5,000,000                    
Preferred stock, par value         $ 0.001                    
Common stock, shares issued         29,846,991 22,630,652                  
Gross proceeds           $ 22,372,000                  
Offering expenses   $ 100,000                          
Net proceeds received from offering after deducting underwriting discount and offering expenses     $ 22,400,000                        
Net proceeds to OncoGenex, from the sale of the units     24,000,000                        
Warrant issuance costs     $ 1,600,000     $ 531,000                  
Stock option exercises, Shares         5,359 10,000 3,475                
Restricted stock unit settlements         269,401 203,148 47,495                
Common shares reserved for options currently outstanding         1,479,221                    
Number Of Warrants Exercised         0                    
Pre-Funded Series B Warrants [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Shares issued in financing, Shares           1,340,538                  
Exercise price per unit of warrant           $ 0.01                  
Common shares purchased, value           $ 13,405                  
2010 Performance Incentive Plan [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Common shares reserved for issuance under various plans         1,756,171 2,906,777                  
Stock available for issuance under performance incentive plan               4,300,000 2,800,000 2,800,000 2,050,000   2,050,000 1,050,000  
Stock options [Member] | 2010 Performance Incentive Plan [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Common shares reserved for issuance under various plans         3,876,151                    
Common shares reserved for options currently outstanding         1,479,221                    
Restricted Stock Unit [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Common shares reserved for awards currently outstanding         640,759 680,201 356,589               172,085
Award vesting period         4 years                    
Restricted Stock Unit [Member] | 2010 Performance Incentive Plan [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Common shares reserved for awards currently outstanding         640,759                    
Minimum [Member] | 2010 Performance Incentive Plan [Member] | Employees and consultants [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period         3 years                    
Minimum [Member] | 2010 Performance Incentive Plan [Member] | Board of Directors [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period         1 year                    
Minimum [Member] | Stock options [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award expiration period         7 years                    
Minimum [Member] | Stock options [Member] | Employees and consultants [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period         3 years                    
Minimum [Member] | Stock options [Member] | Board of Directors [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period         1 year                    
Maximum [Member] | 2010 Performance Incentive Plan [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award expiration period         10 years                    
Maximum [Member] | 2010 Performance Incentive Plan [Member] | Employees and consultants [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period         4 years                    
Maximum [Member] | 2010 Performance Incentive Plan [Member] | Board of Directors [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period         3 years                    
Maximum [Member] | Stock options [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award expiration period         10 years                    
Maximum [Member] | Stock options [Member] | Employees and consultants [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period         4 years                    
Maximum [Member] | Stock options [Member] | Board of Directors [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Award vesting period         3 years                    
Series B Pre-Funded Common Stock Warrants [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Shares issued in financing, Shares     1,340,538                        
Registered Offering, price per unit     $ 3.47                        
Net proceeds to OncoGenex, from the sale of the units     $ 3,387,000                        
Warrant issuance costs     213,000                        
Series A Warrants [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Net proceeds to OncoGenex, from the sale of the units     5,261,000                        
Warrant issuance costs     428,000                        
Exercise price per unit of warrant         $ 4.00                    
Number Of Warrants Exercised           0                  
Series B Warrants [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Net proceeds to OncoGenex, from the sale of the units     1,268,000                        
Warrant issuance costs     $ 103,000                        
Exercise price per unit of warrant         4.00                    
Number Of Warrants Exercised           0                  
Series A-1 Units [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Exercise price per unit of warrant         $ 2.40                    
Series A and Series B Warrants issued in July 2014 Financing [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Number Of Warrants Exercised           0                  
Series A [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Shares issued in financing, Shares     5,559,866                        
Registered Offering, price per unit     $ 3.48                        
Common stock purchase right description         Each Series A unit consisted of one share of common stock and a Series A warrant to purchase up to one-half of one share of common stock at an initial exercise price of $4.00 per share.                    
Series A [Member] | Series A Warrants [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Strike price of warrants     $ 4.00                        
Warrant exercisable period     5 years                        
Series B [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Common stock purchase right description         Each Series B unit consisted of a Pre-Funded Series B warrant to purchase up to one share of common stock at an initial exercise price of $0.01 per share and a Series B warrant to purchase up to one-half of one share of common stock at an initial exercise price of $4.00 per share.                    
Series B [Member] | Series B Pre-Funded Common Stock Warrants [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Strike price of warrants     $ 0.01                        
Warrant exercisable period         5 years                    
Series B [Member] | Series B Warrants [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Strike price of warrants     $ 4.00                        
Warrant exercisable period         5 years                    
MLV [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Common stock sales agreement aggregate offering amount                       $ 25,000,000      
Common stock sales agreement aggregate commission in percentage                       3.00%      
Common stock, shares issued   809,214         0                
Gross proceeds   $ 3,000,000                          
LPC [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Common stock, par value $ 0.001                            
Common stock, shares issued 126,582     6,814,980                      
Gross proceeds $ 0                            
Offering expenses       $ 400,000                      
Common stock value right to sell, maximum 18,000,000                            
Additional common stock value right to sell, maximum $ 16,000,000                            
Additional purchase of common stock, maximum 125,000                            
Gross proceeds       18,000,000                      
Common stock available for sale under offering       $ 0                      
LPC [Member] | Minimum [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Common stock, purchase price $ 1.50                            
LPC [Member] | Series A-1 Units [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Initial purchase of common stock 956,938                            
Common stock, purchase price $ 2.09                            
Purchase agreement, description         Series A-1 Unit consisting of (a) one share of Common Stock and (b) one warrant to purchase one-quarter of a share of Common Stock at an exercise price of $2.40 per share, or Series A-1 Warrant. Each Series A-1 Warrant is exercisable six months following the issuance date until the date that is five years and six months after the issuance date and is subject to customary adjustments.                    
Exercise price per unit of warrant $ 2.40                            
Initial purchase of units consisting of common stock and warrants issued $ 2,000,000                            
LPC [Member] | Other Than Series A-1 Units [Member]                              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                              
Number of warrants issued 0